Characterizing drug-induced stuttering in electronic health records
This study represents the first analysis of health system data examining drugs implicated in drug-induced stuttering in a clinical setting. Augmenting previous case reports and database reviews, a variety of drugs were identified; however, improved reporting of drug-associated speech fluency changes within the EHR are needed to further amass evidence for suspected drugs and their associated epidemiological and clinical characteristics.
Authors
- Douglas M. Shaw (ORCID: https://orcid.org/0000-0001-8896-6659)
- Dillon G. Pruett (ORCID: https://orcid.org/0000-0002-9760-2133)
- Alyssa Scartozzi (ORCID: https://orcid.org/0000-0003-1703-2423)
- Jennifer Elizabeth Below (ORCID: https://orcid.org/0000-0002-1346-1872)
- Shelly Jo Kraft (ORCID: https://orcid.org/0000-0003-0081-2159)
- Megan M. Shuey (ORCID: https://orcid.org/0000-0003-2866-3562)
- Christine Hunter (ORCID: https://orcid.org/0000-0002-2583-2052)
- Robin M. Jones (ORCID: https://orcid.org/0000-0002-1150-0786)
Institutions
- Wayne State University (US)
- Lipscomb University (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- Journal of Communication Disorders
- Published
- 2024-11-19
- DOI
- https://doi.org/10.1016/j.jcomdis.2024.106475
- Citations
- 4
- Primary Topic
- Stuttering Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.56
Funders
- Vanderbilt University
- Wayne State University
- Vanderbilt University Medical Center
- Georgia Clinical and Translational Science Alliance
- National Institutes of Health
- National Institute on Deafness and Other Communication Disorders
- National Center for Advancing Translational Sciences